aTyr Pharma reported $-153K in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Ardelyx USD -37.6M 37.2M Mar/2026
aTyr Pharma USD -153K 24.71M Mar/2026
Biogen USD 97.5M 222M Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Cipla INR 7.89B 2.34B Jun/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -7.67M 64.51M Mar/2026
CSL USD 401M 96.5M Dec/2025
Curis USD -24.2M 43.56M Mar/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
Grifols EUR 114.37M 34.03M Dec/2025
Lakefront Biotherapeutics EUR 2.11M 12.38M Jun/2026
Novartis USD 3.26B 108M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
United Therapeutics USD 333M 58.1M Jun/2026